Evaluation of Disability Progression in Multiple Sclerosis via Magnetic-Resonance-Based Deep Learning Techniques.
deep learning
disability
magnetic resonance imaging
multiple sclerosis
neuroimaging
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
13 Sep 2022
13 Sep 2022
Historique:
received:
06
08
2022
revised:
02
09
2022
accepted:
05
09
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
28
9
2022
Statut:
epublish
Résumé
Short-term disability progression was predicted from a baseline evaluation in patients with multiple sclerosis (MS) using their three-dimensional T1-weighted (3DT1) magnetic resonance images (MRI). One-hundred-and-eighty-one subjects diagnosed with MS underwent 3T-MRI and were followed up for two to six years at two sites, with disability progression defined according to the expanded-disability-status-scale (EDSS) increment at the follow-up. The patients’ 3DT1 images were bias-corrected, brain-extracted, registered onto MNI space, and divided into slices along coronal, sagittal, and axial projections. Deep learning image classification models were applied on slices and devised as ResNet50 fine-tuned adaptations at first on a large independent dataset and secondly on the study sample. The final classifiers’ performance was evaluated via the area under the curve (AUC) of the false versus true positive diagram. Each model was also tested against its null model, obtained by reshuffling patients’ labels in the training set. Informative areas were found by intersecting slices corresponding to models fulfilling the disability progression prediction criteria. At follow-up, 34% of patients had disability progression. Five coronal and five sagittal slices had one classifier surviving the AUC evaluation and null test and predicted disability progression (AUC > 0.72 and AUC > 0.81, respectively). Likewise, fifteen combinations of classifiers and axial slices predicted disability progression in patients (AUC > 0.69). Informative areas were the frontal areas, mainly within the grey matter. Briefly, 3DT1 images may give hints on disability progression in MS patients, exploiting the information hidden in the MRI of specific areas of the brain.
Identifiants
pubmed: 36142563
pii: ijms231810651
doi: 10.3390/ijms231810651
pmc: PMC9505100
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Organisme : Roche
ID : SL41553
Organisme : Fondazione Italiana Sclerosi Multipla (FISM)
ID : FISM/2018/S/3
Références
Neuroimage Clin. 2020;25:102149
pubmed: 31918065
Handb Clin Neurol. 2014;122:343-69
pubmed: 24507525
IEEE Trans Med Imaging. 2016 May;35(5):1299-1312
pubmed: 26978662
AJNR Am J Neuroradiol. 2021 Nov;42(11):1927-1933
pubmed: 34531195
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Cerebellum. 2015 Jun;14(3):364-74
pubmed: 25578034
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Diagn Interv Imaging. 2020 Dec;101(12):795-802
pubmed: 32651155
Mult Scler Relat Disord. 2021 Aug;53:102989
pubmed: 34052741
Radiographics. 2017 Nov-Dec;37(7):2113-2131
pubmed: 29131760
Comput Methods Programs Biomed. 2021 Sep;208:106180
pubmed: 34146771
J Neurol. 2021 Dec;268(12):4834-4845
pubmed: 33970338
Nat Rev Neurol. 2019 May;15(5):287-300
pubmed: 30940920
Lancet Neurol. 2012 May;11(5):467-76
pubmed: 22516081
Radiology. 2020 Feb;294(2):398-404
pubmed: 31845845
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Mult Scler. 2016 Apr;22(4):494-501
pubmed: 26163070
Nat Commun. 2021 Apr 6;12(1):2078
pubmed: 33824310
Neurology. 2019 Jan 22;92(4):180-192
pubmed: 30587516
NMR Biomed. 2020 May;33(5):e4283
pubmed: 32125737
Neuroimage Clin. 2019;24:102003
pubmed: 31634822
Radiology. 2020 Mar;294(3):487-489
pubmed: 31891322
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
PLoS One. 2017 Apr 5;12(4):e0174866
pubmed: 28379999
Mult Scler. 2020 Sep;26(10):1217-1226
pubmed: 31190607
Brain. 2018 Jun 1;141(6):1665-1677
pubmed: 29741648
Mult Scler. 2021 Apr;27(4):519-527
pubmed: 32442043
Neuroimage Clin. 2018;20:724-730
pubmed: 30238916
Magn Reson Imaging. 2020 Jan;65:8-14
pubmed: 31670238
Neuroimage Clin. 2020;25:102104
pubmed: 31927500
Front Neurol. 2020 Jun 30;11:529
pubmed: 32695059
Lancet Neurol. 2014 Aug;13(8):807-22
pubmed: 25008549
Brain. 2010 Jul;133(Pt 7):1900-13
pubmed: 20423930
Invest Radiol. 2022 Jul 1;57(7):423-432
pubmed: 35093968
Mult Scler. 2018 Mar;24(3):322-330
pubmed: 28287331
Med Image Anal. 2017 Dec;42:60-88
pubmed: 28778026
Sci Rep. 2020 Dec 3;10(1):21038
pubmed: 33273676
Hum Brain Mapp. 2019 Oct 1;40(14):4091-4104
pubmed: 31206931
Brain. 2016 Jan;139(Pt 1):115-26
pubmed: 26637488
Mult Scler J Exp Transl Clin. 2019 Nov 06;5(4):2055217319885983
pubmed: 31723436
Med Image Anal. 2018 Oct;49:105-116
pubmed: 30119038
Brain. 2016 Mar;139(Pt 3):807-15
pubmed: 26912645
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Neuroscience. 2019 Apr 1;403:4-16
pubmed: 28764938
IEEE Trans Med Imaging. 1998 Jun;17(3):463-8
pubmed: 9735909
Invest Radiol. 2021 Apr 1;56(4):252-260
pubmed: 33109920